Published in Science on March 14, 2002
Virus attenuation by genome-scale changes in codon pair bias. Science (2008) 5.06
From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol (2010) 3.46
Virulence and competitive ability in genetically diverse malaria infections. Proc Natl Acad Sci U S A (2005) 2.85
Imbroglios of viral taxonomy: genetic exchange and failings of phenetic approaches. J Bacteriol (2002) 2.53
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol (2003) 2.51
Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes. J Virol (2004) 2.44
Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes. BMC Microbiol (2006) 2.33
Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population. J Infect Dis (2011) 2.14
Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region. J Virol (2006) 2.10
Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J Clin Microbiol (2009) 2.01
Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus. Cell Host Microbe (2014) 1.98
Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol (2008) 1.85
Specific capture and whole-genome sequencing of viruses from clinical samples. PLoS One (2011) 1.78
RNA recombination plays a major role in genomic change during circulation of coxsackie B viruses. J Virol (2004) 1.68
Recombinant vaccine-derived poliovirus in Madagascar. Emerg Infect Dis (2003) 1.63
Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication. Proc Natl Acad Sci U S A (2007) 1.60
New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis. Clin Infect Dis (2008) 1.58
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol (2004) 1.55
Eradicating poliomyelitis: India's journey from hyperendemic to polio-free status. Indian J Med Res (2013) 1.50
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol (2013) 1.44
Global efforts to eradicate polio. CMAJ (2004) 1.38
Surveillance of acute flaccid paralysis in the Marches region (Italy): 1997-2007. BMC Infect Dis (2008) 1.36
The role of research in viral disease eradication and elimination programs: lessons for malaria eradication. PLoS Med (2011) 1.34
Impaired binding of standard initiation factors mediates poliovirus translation attenuation. J Virol (2003) 1.33
Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses. Proc Natl Acad Sci U S A (2003) 1.33
Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons. J Virol (2009) 1.32
Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar. PLoS Pathog (2007) 1.31
Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia. J Virol (2004) 1.29
Emerging viral infections of the central nervous system: part 1. Arch Neurol (2009) 1.28
A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease. Nat Med (2012) 1.26
Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future. J Virol (2003) 1.26
Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China. J Virol (2003) 1.25
Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis. J Virol (2002) 1.24
Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses. PLoS Pathog (2009) 1.24
High frequency and diversity of species C enteroviruses in Cameroon and neighboring countries. J Clin Microbiol (2012) 1.24
A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J Virol (2005) 1.23
Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient. J Virol (2005) 1.22
Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants. Front Immunol (2013) 1.19
The final stages of the global eradication of poliomyelitis. Philos Trans R Soc Lond B Biol Sci (2013) 1.18
Multiple recombinant dengue type 1 viruses in an isolate from a dengue patient. J Gen Virol (2007) 1.16
Surveillance of acute flaccid paralysis in Akwa Ibom State, Nigeria 2004-2009. Pan Afr Med J (2011) 1.15
Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication. J Virol (2006) 1.11
Viral quasispecies. Virology (2015) 1.09
Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence. Viruses (2011) 1.08
A nonpolio enterovirus with respiratory tropism causes poliomyelitis in intercellular adhesion molecule 1 transgenic mice. Proc Natl Acad Sci U S A (2004) 1.06
Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient. J Virol (2008) 1.06
Estimating the extent of vaccine-derived poliovirus infection. PLoS One (2008) 1.05
Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative. PLoS Pathog (2015) 1.05
Long-term excretion of vaccine-derived poliovirus by a healthy child. J Virol (2004) 1.02
Multiplex PCR method for identifying recombinant vaccine-related polioviruses. J Clin Microbiol (2004) 1.01
Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine. J Virol (2005) 1.01
Evidence of structural genomic region recombination in Hepatitis C virus. Virol J (2006) 1.01
Genetic relationship between cocirculating Human enteroviruses species C. PLoS One (2011) 1.00
Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization. J Clin Microbiol (2005) 1.00
Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci U S A (2013) 0.99
Biochemical characterization of the fidelity of poliovirus RNA-dependent RNA polymerase. Virol J (2007) 0.99
Development of a poliovirus neutralization test with poliovirus pseudovirus for measurement of neutralizing antibody titer in human serum. Clin Vaccine Immunol (2011) 0.97
An economic analysis of poliovirus risk management policy options for 2013-2052. BMC Infect Dis (2015) 0.96
Natural type 3/type 2 intertypic vaccine-related poliovirus recombinants with the first crossover sites within the VP1 capsid coding region. PLoS One (2010) 0.96
Genus-specific substitution rate variability among picornaviruses. J Virol (2011) 0.96
Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties. J Virol (2006) 0.96
High frequency of human enterovirus species C circulation in Madagascar. J Clin Microbiol (2005) 0.95
Feasibility of quantitative environmental surveillance in poliovirus eradication strategies. Appl Environ Microbiol (2012) 0.95
Nonhomologous recombination between defective poliovirus and coxsackievirus genomes suggests a new model of genetic plasticity for picornaviruses. MBio (2014) 0.95
The risks, costs, and benefits of possible future global policies for managing polioviruses. Am J Public Health (2008) 0.94
A putative loop E motif and an H-H kissing loop interaction are conserved and functional features in a group C enterovirus RNA that inhibits ribonuclease L. RNA Biol (2008) 0.94
Virulence of mixed fungal infections in honey bee brood. Front Zool (2012) 0.94
Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya. BMC Infect Dis (2009) 0.93
Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs. BMC Infect Dis (2015) 0.93
Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine. J Virol (2009) 0.92
Synthetic DNA vaccine strategies against persistent viral infections. Expert Rev Vaccines (2013) 0.92
Development of a reverse transcription-loop-mediated isothermal amplification (RT-LAMP) system for a highly sensitive detection of enterovirus in the stool samples of acute flaccid paralysis cases. BMC Infect Dis (2009) 0.92
Isolation of vaccine-derived polioviruses in the Slovak Republic. Eur J Clin Microbiol Infect Dis (2005) 0.92
Future of polio vaccines. Expert Rev Vaccines (2009) 0.91
Virology. Poliomyelitis eradication--a dangerous endgame. Science (2002) 0.91
Envelope exchange for the generation of live-attenuated arenavirus vaccines. PLoS Pathog (2006) 0.91
Intragenic recombination as a mechanism of genetic diversity in bluetongue virus. J Virol (2010) 0.91
Molecular identification and analysis of human enteroviruses isolated from healthy children in Shenzhen, China from 2010 to 2011. PLoS One (2013) 0.91
Mechanism of action at the molecular level of the antiviral drug 3(2H)-isoflavene against type 2 poliovirus. Antimicrob Agents Chemother (2004) 0.90
Dominant drug targets suppress the emergence of antiviral resistance. Elife (2014) 0.89
Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria. PLoS One (2015) 0.88
Recombination in enteroviruses is a biphasic replicative process involving the generation of greater-than genome length 'imprecise' intermediates. PLoS Pathog (2014) 0.87
Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice. Immunology (2010) 0.86
Evolution and Emergence of Enteroviruses through Intra- and Inter-species Recombination: Plasticity and Phenotypic Impact of Modular Genetic Exchanges in the 5' Untranslated Region. PLoS Pathog (2015) 0.86
Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004-2011. Emerg Infect Dis (2013) 0.85
Lessons from the eradication of smallpox: an interview with D. A. Henderson. Philos Trans R Soc Lond B Biol Sci (2013) 0.85
Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus. J Virol (2008) 0.85
Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes. Plant Biotechnol J (2016) 0.85
Evolution and circulation of type-2 vaccine-derived polioviruses in Nad Ali district of Southern Afghanistan during June 2009-February 2011. PLoS One (2014) 0.84
Molecular epidemiology and recombination of human enteroviruses from AFP surveillance in Yunnan, China from 2006 to 2010. Sci Rep (2014) 0.84
Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China. J Clin Microbiol (2010) 0.83
Productive homologous and non-homologous recombination of hepatitis C virus in cell culture. PLoS Pathog (2013) 0.83
Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame. PLoS Pathog (2016) 0.82
Shedding and reversion of oral polio vaccine type 3 in Mexican vaccinees: comparison of mutant analysis by PCR and enzyme cleavage to a real-time PCR assay. J Clin Microbiol (2007) 0.82
Use of a multiple restriction fragment length polymorphism method for detecting vaccine-derived polioviruses in clinical samples. J Clin Microbiol (2006) 0.82
Virological, serological, and clinical features of an outbreak of acute gastroenteritis due to recombinant genogroup II norovirus in an infant home. J Clin Microbiol (2006) 0.82
An outbreak of type π vaccine-derived poliovirus in Sichuan province, China: emergence and circulation in an under-immunized population. PLoS One (2014) 0.81
Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China. Clin Vaccine Immunol (2014) 0.81
Circulating vaccine derived poliovirus and the polio eradication endgame. Pan Afr Med J (2012) 0.81
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol (2006) 7.56
The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology (2004) 4.95
Severe respiratory illness associated with enterovirus D68 - Missouri and Illinois, 2014. MMWR Morb Mortal Wkly Rep (2014) 4.21
Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature (2006) 3.19
Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr Int (2004) 3.06
Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand. Lancet (2005) 3.01
Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol (2008) 2.74
Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med (2009) 2.73
Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis (2005) 2.55
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol (2003) 2.51
Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region. J Virol (2003) 2.40
Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011. Emerg Infect Dis (2012) 2.26
Instituto Carso de la Salud: a boost for health philanthropy. Lancet (2008) 2.24
Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA (2009) 2.16
Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population. J Infect Dis (2011) 2.14
Risk factors for open-angle glaucoma in a Japanese population: the Tajimi Study. Ophthalmology (2006) 2.14
Sodium intake and risk of death from stroke in Japanese men and women. Stroke (2004) 2.10
Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region. J Virol (2006) 2.10
Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens. J Clin Microbiol (2011) 2.07
Genetic and antigenic diversity among noroviruses. J Gen Virol (2006) 1.91
Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ (2004) 1.90
Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90. EMBO J (2006) 1.89
Sleep disturbance and onset of type 2 diabetes. Diabetes Care (2004) 1.88
Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. J Virol (2005) 1.86
Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology (2007) 1.82
Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc Natl Acad Sci U S A (2009) 1.82
Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. Ophthalmology (2006) 1.81
Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis. J Infect Dis (2003) 1.79
Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J Med Virol (2002) 1.78
Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio (2014) 1.76
Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein. J Virol (2003) 1.76
Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis (2007) 1.76
Infant deaths associated with human parechovirus infection in Wisconsin. Clin Infect Dis (2010) 1.75
The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology (2005) 1.75
Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein. J Biochem (2006) 1.71
The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog (2011) 1.70
Measles and rubella elimination initiatives in the Americas: lessons learned and best practices. J Infect Dis (2011) 1.67
Resolving ambiguities in genetic typing of human enterovirus species C clinical isolates and identification of enterovirus 96, 99 and 102. J Gen Virol (2009) 1.67
Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab (2009) 1.66
Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J Virol (2008) 1.65
Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J Virol (2008) 1.65
Etiology and Incidence of viral and bacterial acute respiratory illness among older children and adults in rural western Kenya, 2007-2010. PLoS One (2012) 1.64
Urinary prostate cancer 3 test: toward the age of reason? Urology (2009) 1.64
Detection of all known parechoviruses by real-time PCR. J Clin Microbiol (2008) 1.61
A fatal central nervous system enterovirus 68 infection. Arch Pathol Lab Med (2011) 1.61
Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J Gen Virol (2005) 1.60
Pathogenesis of lipid metabolism disorder in hepatitis C: polyunsaturated fatty acids counteract lipid alterations induced by the core protein. J Hepatol (2010) 1.58
"Eczema coxsackium" and unusual cutaneous findings in an enterovirus outbreak. Pediatrics (2013) 1.57
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol (2004) 1.55
Non-Newtonian blood flow in human right coronary arteries: steady state simulations. J Biomech (2004) 1.55
First use of investigational antiviral drug pocapavir (v-073) for treating neonatal enteroviral sepsis. Pediatr Infect Dis J (2015) 1.54
Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol (2007) 1.54
An outbreak of wild poliovirus in the Republic of Congo, 2010-2011. Clin Infect Dis (2012) 1.53
New vaccines for developing countries: will it be feast or famine? Am J Law Med (2009) 1.51
Guidelines for the documentation and verification of measles, rubella, and congenital rubella syndrome elimination in the region of the Americas. J Infect Dis (2011) 1.46
An outbreak of concurrent echovirus 30 and coxsackievirus A1 infections associated with sea swimming among a group of travelers to Mexico. Clin Infect Dis (2008) 1.45
Non-Newtonian blood flow in human right coronary arteries: transient simulations. J Biomech (2006) 1.45
Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci U S A (2007) 1.45
Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983-2003. Pediatr Infect Dis J (2006) 1.44
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol (2013) 1.44
Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. J Virol (2005) 1.43
Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J Gen Virol (2004) 1.43
Assessing and monitoring vaccination coverage levels: lessons from the Americas. Rev Panam Salud Publica (2004) 1.42
An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol (2007) 1.41
Intramembrane proteolysis and endoplasmic reticulum retention of hepatitis C virus core protein. J Virol (2004) 1.40
Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity. J Virol (2010) 1.40
Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J Biol Chem (2010) 1.40
Relation between VE/VCO2 slope and maximum phonation time in chronic heart failure patients. Medicine (Baltimore) (2014) 1.39
Anatomical analysis of different hemispherotomy procedures based on dissection of cadaveric brains. J Neurosurg (2002) 1.39
The feasibility of identifying children with primary immunodeficiency disorders: preparation for the polio post-eradication era in Bangladesh. Vaccine (2012) 1.38
Primary amenorrhea accompanied by adrenal adenoma: start of menarche soon after tumor resection. Intern Med (2002) 1.37
The future of immunisation policy, implementation, and financing. Lancet (2011) 1.36
Molecular typing and epidemiology of non-polio enteroviruses isolated from Yunnan Province, the People's Republic of China. J Med Virol (2008) 1.34
Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005. J Infect Dis (2008) 1.34
A norovirus protease structure provides insights into active and substrate binding site integrity. J Virol (2005) 1.34
Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons. J Virol (2009) 1.32
Hand, foot, and mouth disease caused by coxsackievirus a6. Emerg Infect Dis (2012) 1.32